News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-20 5:2:33 am Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia GlobeNewsWire
2024-03-19 5:0:0 am Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024 GlobeNewswire
2024-03-12 5:0:0 am Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring GlobeNewswire
2024-03-12 4:34:0 am TNXP: Tonmya™ May Launch Alongside Another New Fibromyalgia Treatment… Zacks Small Cap Research
2024-03-11 5:0:0 am Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia GlobeNewswire
2024-03-07 6:37:0 am New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT GlobeNewswire
2024-03-07 5:0:0 am Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy GlobeNewswire
2024-03-06 5:0:0 am Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia GlobeNewswire
2024-03-05 5:0:0 am Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information